TY - CHAP M1 - Book, Section TI - Hepatocellular Carcinoma A1 - Qadan, Motaz A1 - Jarnagin, William R. A2 - Morita, Shane Y. A2 - Balch, Charles M. A2 - Klimberg, V. Suzanne A2 - Pawlik, Timothy M. A2 - Posner, Mitchell C. A2 - Tanabe, Kenneth K. PY - 2018 T2 - Textbook of Complex General Surgical Oncology AB - Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and accounts for the third most cancer deaths worldwide (Fig. 127-1). Although geographic variability exists in the incidence of the disease, occurring less commonly in the United States and Europe, its incidence is steadily rising, having tripled in the United States since the 1970s and projected to increase over the next 20 years (Table 127-1). The current incidence of HCC in the Western world is estimated at 3% to 4% with 5-year survival estimated to be 16% for all-comers.1 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1145763831 ER -